Haleon (LSE:HLN) Just Gave Investors Something To Think About

Haleon (LSE:HLN) has become a talking point after Jefferies cut its rating to hold, with investors weighing lower sales guidance, softer demand outside oral health, and a regulatory setback for Centrum in China.

The recent downgrade and guidance cut sit against a mixed share performance. Haleon’s 7-day share price return of 7.24% and 1-day move of 0.92% hint at a short-term rebound, while the 90-day share price return is down 7.77% and the 1-year total shareholder return is down 3.04%, suggesting momentum has faded over a longer stretch.

Broaden your watchlist beyond Haleon by scanning a hand-picked list of solid balance sheet and fundamentals (9 results) that may better fit how you see this downgrade and guidance reset.

After the downgrade, guidance cut, and launch of a sizeable buyback, Haleon sits at an awkward crossroads. It is unclear whether it makes more sense to step in after this bounce or wait for a clearer entry on valuation grounds.

Most Popular Narrative: 18.5% Undervalued

On the most followed view, Haleon’s narrative fair value of £4.18 sits well above the recent £3.41 close. This puts the recent broker downgrade against a still supportive long term story built around execution and efficiency.

The main thing that has to go right is that Haleon turns its cost savings, AI driven efficiencies and local manufacturing investments in India and China into sustained profit growth while managing weaker respiratory seasons.

The current valuation implies Haleon is fairly valued with the market already pricing in continued growth from oral health, emerging markets and productivity gains alongside ongoing risk around the 4 to 6% organic growth ambition.

See why 55 investors see Haleon as 18% undervalued.

Result: Fair Value of £4.18 (UNDERVALUED)

Still, the narrative around Haleon could unravel if group organic growth stays closer to the recent 2.6% pace and weakness in Respiratory Health proves persistent.

Find out about the key risks to this Haleon narrative.

Next Steps

If the split sentiment around Haleon leaves you unsure, consider reviewing its 4 key rewards and 1 important warning sign while the data is current so you can form your own view.

Looking for more investment ideas beyond Haleon?

If Haleon has sharpened your focus on quality and timing, you can use that same edge to scan for other opportunities that better match your risk and return goals.

• Target potential mispricings by reviewing a curated 15 high quality undervalued stocks that aligns strong fundamentals with compressed expectations.
• Explore income potential by scanning a focused group of 6 dividend fortresses that pair higher yields with resilient payout histories.
• Manage downside exposure by filtering for 4 resilient stocks with low risk scores that combine sturdier balance sheets with more measured volatility profiles.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com